Our investigation of glioma cell and tissue microarrays reveals a significant upregulation of Rab32 in glioma specimens, which demonstrates a positive correlation with tumor grade and unfavorable patient prognosis. This evidence concerns the gene RAB32 and central nervous system cancer.